Research ExplorerPublicationsAberrant O-GalNAc glycosylation to enhance AKT/mTOR signalin...

Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.

Standard

Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer. / Hofmann, Bianca Thidahan; Kwiatkowski, Marcel; Izbicki, Jakob; Bockhorn, Maximilian; Güngör, Cenap; Ewald, Florian; Wolters-Eisfeld, Gerrit.

In: J CLIN ONCOL, Vol. 34, No. 15_suppl, 20.05.2016, p. e15673-e15673.

Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

Harvard

Hofmann, BT, Kwiatkowski, M, Izbicki, J, Bockhorn, M, Güngör, C, Ewald, F & Wolters-Eisfeld, G 2016, 'Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.', J CLIN ONCOL, vol. 34, no. 15_suppl, pp. e15673-e15673. https://doi.org/DOI: 10.1200/JCO.2016.34.15_suppl.e15673

APA

Hofmann, B. T., Kwiatkowski, M., Izbicki, J., Bockhorn, M., Güngör, C., Ewald, F., & Wolters-Eisfeld, G. (2016). Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer. J CLIN ONCOL, 34(15_suppl), e15673-e15673. https://doi.org/DOI: 10.1200/JCO.2016.34.15_suppl.e15673

Vancouver

Hofmann BT, Kwiatkowski M, Izbicki J, Bockhorn M, Güngör C, Ewald F et al. Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer. J CLIN ONCOL. 2016 May 20;34(15_suppl):e15673-e15673. https://doi.org/DOI: 10.1200/JCO.2016.34.15_suppl.e15673

Bibtex

@article{bfd80f0f9646462cab6e24cc739246c5,
title = "Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.",
author = "Hofmann, {Bianca Thidahan} and Marcel Kwiatkowski and Jakob Izbicki and Maximilian Bockhorn and Cenap G{\"u}ng{\"o}r and Florian Ewald and Gerrit Wolters-Eisfeld",
year = "2016",
month = may,
day = "20",
doi = "DOI: 10.1200/JCO.2016.34.15_suppl.e15673",
language = "English",
volume = "34",
pages = "e15673--e15673",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "15_suppl",

}

RIS

TY - JOUR

T1 - Aberrant O-GalNAc glycosylation to enhance AKT/mTOR signaling in pancreatic cancer.

AU - Hofmann, Bianca Thidahan

AU - Kwiatkowski, Marcel

AU - Izbicki, Jakob

AU - Bockhorn, Maximilian

AU - Güngör, Cenap

AU - Ewald, Florian

AU - Wolters-Eisfeld, Gerrit

PY - 2016/5/20

Y1 - 2016/5/20

U2 - DOI: 10.1200/JCO.2016.34.15_suppl.e15673

DO - DOI: 10.1200/JCO.2016.34.15_suppl.e15673

M3 - Conference abstract in journal

VL - 34

SP - e15673-e15673

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 15_suppl

ER -